Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
29,149,043
-
Total 13F shares
-
8,107,805
-
Share change
-
+1,221,445
-
Total reported value
-
$348,975,660
-
Put/Call ratio
-
128%
-
Price per share
-
$43.07
-
Number of holders
-
94
-
Value change
-
+$52,845,612
-
Number of buys
-
69
-
Number of sells
-
30
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q2 2014
As of 30 Jun 2014,
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,107,805 shares.
The largest 10 holders included
FMR LLC, Consonance Capital Management LP, EAGLE ASSET MANAGEMENT INC, SENZAR ASSET MANAGEMENT, LLC, BlackRock Fund Advisors, WALL STREET ASSOCIATES, GLENMEDE TRUST CO NA, VANGUARD GROUP INC, INSIGHT CAPITAL RESEARCH & MANAGEMENT INC, and CADENCE CAPITAL MANAGEMENT LLC.
This page lists
94
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.